amantadine has been researched along with MPTP Neurotoxicity Syndrome in 5 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnston, TH | 1 |
| Huot, P | 1 |
| Fox, SH | 1 |
| Koprich, JB | 1 |
| Szeliga, KT | 1 |
| James, JW | 1 |
| Graef, JD | 1 |
| Letchworth, SR | 1 |
| Jordan, KG | 1 |
| Hill, MP | 3 |
| Brotchie, JM | 2 |
| Ko, WK | 1 |
| Pioli, E | 1 |
| Li, Q | 1 |
| McGuire, S | 1 |
| Dufour, A | 1 |
| Sherer, TB | 1 |
| Bezard, E | 2 |
| Facheris, MF | 1 |
| Kobylecki, C | 1 |
| Crossman, AR | 2 |
| Ravenscroft, P | 2 |
| Kim, JH | 1 |
| Lee, HW | 1 |
| Hwang, J | 1 |
| Kim, J | 1 |
| Lee, MJ | 1 |
| Han, HS | 1 |
| Lee, WH | 1 |
| Suk, K | 1 |
| Michel, A | 1 |
| Grimée, R | 1 |
| Klitgaard, H | 1 |
5 other studies available for amantadine and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
TC-8831, a nicotinic acetylcholine receptor agonist, reduces L-DOPA-induced dyskinesia in the MPTP macaque.
Topics: Amantadine; Animals; Azabicyclo Compounds; Cyclopropanes; Dose-Response Relationship, Drug; Dyskines | 2013 |
Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease.
Topics: Amantadine; Analysis of Variance; Animals; Antiparkinson Agents; Disease Models, Animal; Dose-Respon | 2014 |
Synergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease.
Topics: Amantadine; Animals; Antiparkinson Agents; Behavior, Animal; Callithrix; Disease Models, Animal; Dop | 2011 |
Microglia-inhibiting activity of Parkinson's disease drug amantadine.
Topics: Amantadine; Analysis of Variance; Animals; Antiparkinson Agents; Calcium-Binding Proteins; Cell Line | 2012 |
Levetiracetam potentiates the antidyskinetic action of amantadine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease.
Topics: Amantadine; Animals; Anticonvulsants; Antiparkinson Agents; Callithrix; Disease Models, Animal; Drug | 2004 |